Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy

• Shiwani Randhawa,
• Trilok Chand Saini,
• Manik Bathla,
• Rahul Bhardwaj,
• Rubina Dhiman and
• Amitabha Acharya

Beilstein J. Nanotechnol. 2025, 16, 561–580, doi:10.3762/bjnano.16.44

• of AD by targeting AβOs is crucial for improving outcomes. Current imaging methods, such as computed tomography (CT)/positron emission tomography (PET) with FDA-approved 18F-radiotracers (e.g., Amyvid™ and Tauvid™), detect plaques and tau tangles but not AβOs [13]. There is an urgent need for agents

Realizing active targeting in cancer nanomedicine with ultrasmall nanoparticles

• André F. Lima,
• Giselle Z. Justo and
• Alioscka A. Sousa

Beilstein J. Nanotechnol. 2024, 15, 1208–1226, doi:10.3762/bjnano.15.98

• imaging [20][40], and positron emission tomography [45][46]. In therapeutic applications, usNPs have been used for drug delivery as well as served as phototherapeutic agents and radiosensitizers [47][48][49][50][51]. A distinguishing feature of usNPs is their transient, short-lived interactions with

• radiotherapy and delaying tumor growth (Figure 4C–E). Chen et al. designed dye-labeled (Cy5) and radioiodinated (124I or 131I) C’ dots for dual-modality NIR optical and positron emission tomography (PET) tumor imaging. Furthermore, the particles contained the cRGDY peptide for the targeting of αvβ3-positive

• et al., “Chemokine Receptor 2 Targeted Gold Nanocluster Imaging Triple Negative Breast Cancer with Positron Emission Tomography”, Particle & Particle Systems Characterization, with permission from John Wiley and Sons. Copyright © 2021 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. Germany. This content

Entry of nanoparticles into cells and tissues: status and challenges

• Kirsten Sandvig,
• Tore Geir Iversen and
• Tore Skotland

Beilstein J. Nanotechnol. 2024, 15, 1017–1029, doi:10.3762/bjnano.15.83

• imaging (i.e., positron emission tomography (PET), single-photon emission computed tomography (SPECT), optical/fluorescence, magnetic resonance imaging (MRI), computed tomography (CT; using X-ray) and ultrasound imaging), and the spatial resolution, depth of imaging, sensitivity, and advantages

Intracranial recording in patients with aphasia using nanomaterial-based flexible electronics: promises and challenges

• Qingchun Wang and
• Wai Ting Siok

Beilstein J. Nanotechnol. 2021, 12, 330–342, doi:10.3762/bjnano.12.27

• processing. This review presents findings on aphasia, an impairment in language and communication, and discusses how different brain imaging techniques, including positron emission tomography, magnetic resonance imaging, and iEEG, have advanced our understanding of the neural networks underlying language and

• neuroimaging methods such as positron emission tomography (PET), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), diffusion tensor imaging (DTI), electroencephalography (EEG), magnetoencephalography (MEG), and intracranial electroencephalography (iEEG). Each of these methods has

Differences in surface chemistry of iron oxide nanoparticles result in different routes of internalization

• Barbora Svitkova,
• Vlasta Zavisova,
• Veronika Nemethova,
• Martina Koneracka,
• Miroslava Kretova,
• Filip Razga,
• Monika Ursinyova and
• Alena Gabelova

Beilstein J. Nanotechnol. 2021, 12, 270–281, doi:10.3762/bjnano.12.22

• ; Introduction Magnetic iron oxide nanoparticles (MNPs) as chemically inert material have been increasingly employed as contrast agents in magnetic resonance imaging (MRI), positron emission tomography (PET), and near-infrared fluorescence (NIRF) imaging [1]. The superparamagnetic properties of MNPs make them

Rational design of block copolymer self-assemblies in photodynamic therapy

• Maxime Demazeau,
• Laure Gibot,
• Anne-Françoise Mingotaud,
• Patricia Vicendo,
• Clément Roux and
• Barbara Lonetti

Beilstein J. Nanotechnol. 2020, 11, 180–212, doi:10.3762/bjnano.11.15

• addition of Gd3+ ions (magnetic resonance imaging, MRI) or 64Cu2+ (positron emission tomography, PET). A pH-sensitive acetal bond between poly(ε-caprolactone) and porphyrin was used to release porphyrin at pH 5 (Figure 5c) [79]. In a poly(ethylene glycol)-block-poly(ε-caprolactone) polymer conjugated with

The systemic effect of PEG-nGO-induced oxidative stress in vivo in a rodent model

• Qura Tul Ain,
• Samina Hyder Haq,
• Abeer Alshammari,
• Moudhi Abdullah Al-Mutlaq and
• Muhammad Naeem Anjum

Beilstein J. Nanotechnol. 2019, 10, 901–911, doi:10.3762/bjnano.10.91

• has been utilized as a potent radiotracer and drug-delivery agent in vivo using positron emission tomography (PET) imaging by Jang and co-workers [31]. Liu et al. [32][33] used PEG for the first time to functionalize GO, which can then be use as a vehicle for anticancer drugs such as doxorubicin. The

Targeting strategies for improving the efficacy of nanomedicine in oncology

• Gonzalo Villaverde and
• Alejandro Baeza

Beilstein J. Nanotechnol. 2019, 10, 168–181, doi:10.3762/bjnano.10.16

• with high specificity and due to this property it has been incorporated on the surface of MSN labelled with 64Cu in order to perform imaging by positron emission tomography (PET) [27]. The injection of these particles into the blood stream of mice bearing breast tumour allowed for the visualization of

Calcium fluoride based multifunctional nanoparticles for multimodal imaging

• Marion Straßer,
• Joachim H. X. Schrauth,
• Sofia Dembski,
• Daniel Haddad,
• Bernd Ahrens,
• Stefan Schweizer,
• Bastian Christ,
• Alevtina Cubukova,
• Marco Metzger,
• Heike Walles,
• Peter M. Jakob and
• Gerhard Sextl

Beilstein J. Nanotechnol. 2017, 8, 1484–1493, doi:10.3762/bjnano.8.148

• examination, contrast-rich methods such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) and ultrasonic techniques are being used increasingly for imaging soft tissue, e.g., cartilage imaging in progressive osteoarthritis. Advantages of different imaging

Multiwalled carbon nanotube hybrids as MRI contrast agents

• Nikodem Kuźnik and
• Mateusz M. Tomczyk

Beilstein J. Nanotechnol. 2016, 7, 1086–1103, doi:10.3762/bjnano.7.102

• allow for additional activity in other techniques (e.g., computed tomography (CT), positron emission tomography PET and optical methods). It has been shown that nanomaterials could be more effective than classical CAs by 2–100 times in their activity and lead to dose reductions by 1–2 orders of

Simultaneous cancer control and diagnosis with magnetic nanohybrid materials

• Reza Saadat and
• Franz Renz

Beilstein J. Nanotechnol. 2016, 7, 121–125, doi:10.3762/bjnano.7.14

• Reza Saadat Franz Renz Institute for Inorganic Chemistry, Leibniz University Hannover, Callinstr. 3–9, 30169 Hannover, Germany 10.3762/bjnano.7.14 Abstract Coated magnetite nanoparticles were linked to 68Ga complexes used in the positron emission tomography (PET) for a new technical approach to

• complexes in order to use them as a new type of radiopharmaceuticals. Keywords: biocompatible nanoparticles; cancer control; cancer diagnosis; magnetite nanoparticles; positron emission tomography; Introduction In the field of diagnostic investigation of metabolic diseases imaging methods based on

• nanotechnology have been recently gaining more and more importance [1][2]. In the last 30 years the positron emission tomography (PET) has acquired relevance among the current conventional imaging methods such as X-ray, computed tomography (CT) or magnetic resonance imaging (MRI) [3]. PET gives insights in the